Related Experiment Video
Updated: Jun 7, 2026
04:50
Preliminary Study on Acupuncture Combined with Grain-sized Moxibustion for Treating Rheumatoid Arthritis with Finger Joint Pain
Published on: May 16, 2025
Use of methotrexate in patients with uveitis
1Casey Eye Institute, Portland, OR 97239, USA.
Clinical and Experimental Rheumatology
|November 4, 2010
Summary
Methotrexate effectively treats various ocular inflammatory diseases like uveitis. However, its efficacy for eye conditions requires further investigation through randomized, placebo-controlled trials.
Area of Science:
- Ophthalmology
- Rheumatology
- Immunology
Background:
- Methotrexate is a common treatment for ocular inflammatory conditions such as uveitis, scleritis, and orbital inflammatory disease.
- It has shown effectiveness in treating intraocular lymphoma via direct ocular administration.
Purpose of the Study:
- To review the existing literature on the efficacy of methotrexate in treating ocular inflammatory diseases.
- To identify the need for randomized, placebo-controlled studies evaluating methotrexate for eye conditions.
Main Methods:
- Literature review of studies on methotrexate for ocular inflammatory diseases.
- Analysis of existing data on its use in uveitis, scleritis, orbital inflammatory disease, and intraocular lymphoma.
Main Results:
- Methotrexate is frequently used for various ocular inflammatory conditions.
- Evidence suggests efficacy for intraocular lymphoma when administered directly into the eye.
- A significant gap exists in randomized, placebo-controlled trial data for its use in ocular diseases.
Conclusions:
- Methotrexate is a recognized therapeutic agent for ocular inflammation.
- Further rigorous clinical trials are necessary to definitively establish its efficacy and safety profile in a randomized, placebo-controlled setting for diverse ocular conditions.
Related Concept Videos
01:29Drugs for Treatment of Crohn's Disease in IBD Using Immunomodulatory Agents
Crohn's disease is an inflammatory bowel disorder marked by chronic inflammation of the GI tract. Various treatment strategies for Crohn's disease are employed, such as immunomodulatory agents, glucocorticoids, and biologics or anti-TNF therapy. Azathioprine (Imuran), a commonly used immunomodulatory drug for Crohn's disease, is converted in the body to mercaptopurine, which inhibits purine biosynthesis and cell proliferation. Both are utilized in severe cases of Inflammatory Bowel Disease...
01:29Therapeutic Drug Monitoring: Affecting Factors
Therapeutic Drug Monitoring (TDM) is the clinical practice of measuring specific drug levels in a patient's blood or body tissues to manage and optimize therapy. TDM is crucial for drugs with narrow therapeutic windows, like warfarin and phenytoin, where incorrect doses can lead to treatment failure or severe side effects. This monitoring ensures the dosage administered is within a safe and effective range. The factors affecting therapeutic drug monitoring include:Patient-Specific Factors:a.
01:24Drugs for Treatment of Crohn's Disease in IBD Using Biologic Agents: Anti-TNF
Tumor Necrosis Factor (TNF), a proinflammatory cytokine, contributes significantly to the inflammation seen in Crohn's disease. It exists as soluble TNF and membrane-bound TNF, with actions mediated through TNF receptors (TNFR). TNFR activation leads to the release of proinflammatory cytokines, T-cell activation, collagen production, and leukocyte migration, all contributing to inflammation in Crohn's disease. Anti-TNF monoclonal antibodies, namely infliximab (Remicade), adalimumab (Humira),...
01:21Drugs for Treatment of Crohn's Disease in IBD Using Glucocorticoids
Glucocorticoids, a class of anti-inflammatory drugs, are pivotal in treating moderate to severe Crohn's disease by inducing remission. They exhibit their anti-inflammatory action by inhibiting the production of inflammatory cytokines such as tumor necrosis factor (TNF)-α, interleukin (IL)-1, and chemokines like IL-8. In addition, they reduce the expression of inflammatory cell adhesion molecules and inhibit gene transcription of nitric oxide synthase, phospholipase A2, cyclooxygenase-2 (COX-2),...
01:29Drugs for Treatment of Ulcerative Colitis in IBD
Ulcerative colitis is a chronic inflammatory condition primarily affecting the colon and rectum. The primary drugs used in the treatment of ulcerative colitis are aminosalicylates. They exhibit anti-inflammatory and immunosuppressive properties. They modulate inflammatory mediators and inhibit the activity of nuclear factor κB (NF-κB). Aminosalicylates also reduce inflammation by inhibiting prostaglandin and leukotriene production and decreasing neutrophil chemotaxis and superoxide generation.
01:27Open Angle Glaucoma: Treatment
In open-angle glaucoma, the iridocorneal angle remains open, but the trabecular meshwork becomes stiff, slowing down the outflow of aqueous humor. This causes a buildup of aqueous humor in the anterior chamber, leading to a sudden increase in intraocular pressure. The treatment for open-angle glaucoma focuses on reducing the elevated intraocular pressure by either decreasing the secretion of aqueous humor or increasing its outflow.
Drugs such as carbonic anhydrase inhibitors, α2- and...
Drugs such as carbonic anhydrase inhibitors, α2- and...